<DOC>
	<DOC>NCT00170859</DOC>
	<brief_summary>In this study two immunosuppressive regimens (everolimus in combination with cyclosporine microemulsion and mycophenolate mofetil with cyclosporine microemulsion) with reduced dose cyclosporine microemulsion are compared in maintenance heart transplant recipients with impaired renal function.</brief_summary>
	<brief_title>Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Recipients of primary heart transplant Reduced renal function (serum creatinine &gt; 1.7 ng/mL over 2 months or more) at 6 months or more after heart transplantation Patients with current immunosuppressive therapy consisting of cyclosporine microemulsion and mycophenolate mofetil Patients who are recipients of multiple organ transplants Patients who have previously received an organ transplant Patients with serum creatinine &gt; 3.5 mg/dl Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>everolimus</keyword>
	<keyword>cyclosporine microemulsion</keyword>
	<keyword>renal function</keyword>
</DOC>